Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders Post date 4 November 2021 ← Whole genome sequencing helps pinpoint a genetic diagnosis for patients → Shortening the diagnostic odyssey—the impact of whole genome sequencing in the NHS